Vera Therapeutics(VERA) - 2025 Q4 - Annual Results

Exhibit 99.1 Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results BRISBANE, Calif., February 26, 2026 – Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical- stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business highlights and financial results for the full year ended December 31, 2025. "In 2025, Vera Therapeutics delivered on several key milestones as ...